Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 237

Results For "CENT"

4467 News Found

Cenexi appoints Jim McPherson as CEO
People | September 20, 2023

Cenexi appoints Jim McPherson as CEO

Prior to this, Jim held leadership positions at several companies, including Centrient Pharmaceuticals, Leo Pharmaceuticals, Sandoz, Xellia, and GSK


CureVac highlights shift to mRNA technology in seasonal influenza vaccine development: GlobalData
Clinical Trials | September 19, 2023

CureVac highlights shift to mRNA technology in seasonal influenza vaccine development: GlobalData

CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology


Ojjaara approved in the US as the first and only treatment for myelofibrosis patients with anaemia
Drug Approval | September 19, 2023

Ojjaara approved in the US as the first and only treatment for myelofibrosis patients with anaemia

Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy


CAHO and PFPSF launch Patient Advisory Councils
Healthcare | September 18, 2023

CAHO and PFPSF launch Patient Advisory Councils

Patient Advisory Councils (PACs) to be set up across hospitals to make patients true partners in enhancing patient safety and improving care delivery


Merck receives positive EU CHMP opinion for Keytruda as adjuvant treatment for  cell lung cancer
Drug Approval | September 18, 2023

Merck receives positive EU CHMP opinion for Keytruda as adjuvant treatment for cell lung cancer

Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial


Dr. Jitendra Singh flags off SMVD Narayana Healthcare TB Mukt Express
Healthcare | September 18, 2023

Dr. Jitendra Singh flags off SMVD Narayana Healthcare TB Mukt Express

Public private partnership (PPP) with integrated strategy essential to achieve ‘TB Mukt Bharat’ by 2025


Strides receives tentative USFDA approval for Dolutegravir tablets
Drug Approval | September 15, 2023

Strides receives tentative USFDA approval for Dolutegravir tablets

The products will be manufactured at the company's facility in Bengaluru


Sun Pharma and Pharmazz ink agreement for introducing Tyvalzi in India
News | September 15, 2023

Sun Pharma and Pharmazz ink agreement for introducing Tyvalzi in India

Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)


Narayana Health unveils new brand identity
News | September 15, 2023

Narayana Health unveils new brand identity

The new logo incorporates three beating hearts seamlessly & reinforces 'healthcare with a heart' into the Group's visual identity


Ami Organics to supply additional API to Fermion
News | September 15, 2023

Ami Organics to supply additional API to Fermion

The product is expected to start contributing meaningfully to the revenue from FY25